Literature DB >> 23127084

Quality assurance and independent dosimetry for an intraoperative x-ray device.

D J Eaton1.   

Abstract

PURPOSE: Quality assurance is an essential component of accurate and safe radiotherapy delivery, and should include measurements which are independent of manufacturer-provided calibration. However, the physical and dosimetric properties of the INTRABEAM compact mobile 50 kV x-ray source are different from conventional kilovoltage therapy units and few reports describe methods for independent checks, frequencies, or tolerances for quality assurance tests.
METHODS: Based on the available evidence and local experience, methods are described for determination of the key dosimetric parameters: beam quality, output, isotropy, and depth doses. Internal system checks are also described, along with measurements of long-term stability.
RESULTS: A small volume parallel plate ionization chamber in a liquid water tank is the gold standard for measurements with this unit, but solid water-equivalent materials, thermoluminescent dosimeters and radiochromic film can all be used as practical alternatives with an accuracy of 5%-10%. The main cause of measurement uncertainty is positioning of the detector in the steep dose gradient, but energy dependence should also be considered.
CONCLUSIONS: A quality assurance schedule with suggested tolerances is proposed, which includes both internal tests, before each treatment and on a monthly basis, and independent tests every year or after servicing or recalibration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23127084     DOI: 10.1118/1.4761865

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  18 in total

1.  A national dosimetry audit of intraoperative radiotherapy.

Authors:  D J Eaton; B Earner; P Faulkner; N Dancer
Journal:  Br J Radiol       Date:  2013-10-16       Impact factor: 3.039

Review 2.  Electronic brachytherapy--current status and future directions.

Authors:  D J Eaton
Journal:  Br J Radiol       Date:  2015-03-06       Impact factor: 3.039

3.  Dosimetric characteristics of the INTRABEAM ® system with spherical applicators in the presence of air gaps and tissue heterogeneities.

Authors:  Eyachew Misganew Tegaw; Somayeh Gholami; Gilnaz Omyan; Ghazale Geraily
Journal:  Radiat Environ Biophys       Date:  2020-03-31       Impact factor: 1.925

Review 4.  Present state and issues in IORT Physics.

Authors:  Frank W Hensley
Journal:  Radiat Oncol       Date:  2017-01-27       Impact factor: 3.481

5.  Therapeutic analysis of Intrabeam-based intraoperative radiation therapy in the treatment of unicentric breast cancer lesions utilizing a spherical target volume model.

Authors:  Madeline Schwid; Eric D Donnelly; Hualin Zhang
Journal:  J Appl Clin Med Phys       Date:  2017-07-25       Impact factor: 2.102

6.  Commissioning a 50-100 kV X-ray unit for skin cancer treatment.

Authors:  Ren-Dih Sheu; Allison Powers; Yeh-Chi Lo
Journal:  J Appl Clin Med Phys       Date:  2015-03-08       Impact factor: 2.102

Review 7.  Novel treatment options for nonmelanoma skin cancer: focus on electronic brachytherapy.

Authors:  Michael E Kasper; Ahmed A Chaudhary
Journal:  Med Devices (Auckl)       Date:  2015-11-26

8.  A novel approach for superficial intraoperative radiotherapy (IORT) using a 50 kV X-ray source: a technical and case report.

Authors:  Frank Schneider; Sven Clausen; Johannes Thölking; Frederik Wenz; Yasser Abo-Madyan
Journal:  J Appl Clin Med Phys       Date:  2014-01-06       Impact factor: 2.102

9.  Intraoperative Radiotherapy With INTRABEAM: Technical and Dosimetric Considerations.

Authors:  Anil Sethi; Bahman Emami; William Small; Tarita O Thomas
Journal:  Front Oncol       Date:  2018-03-26       Impact factor: 6.244

10.  INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus.

Authors:  Xiaodong Song; Yong He; Huihong Liang; Menling Han; Zili Shao
Journal:  BMC Surg       Date:  2020-08-01       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.